ethics enalapril
multichem nz limited - enalapril maleate 5mg; ; - tablet - 5 mg - active: enalapril maleate 5mg excipient: croscarmellose sodium hypromellose lactose monohydrate maleic acid sodium stearyl fumarate - all grades of essential hypertension.
enalapril maleate tablet
oceanside pharmaceuticals - enalapril maleate (unii: 9o25354epj) (enalaprilat anhydrous - unii:q508q118jm) - enalapril maleate 2.5 mg - hypertension enalapril maleate tablets are indicated for the treatment of hypertension. enalapril maleate tablets are effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of enalapril maleate tablets and thiazides are approximately additive. heart failure enalapril maleate tablets are indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. in these patients enalapril maleate tablets improve symptoms, increases survival, and decreases the frequency of hospitalization (see clinical pharmacology, heart failure, mortality trials for details and limitations of survival trials). asymptomatic left ventricular dysfunction in clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction ≤35 percent), enalapril maleate tablets decrease the rate of development of overt heart failure and decreases the incidence of hospitalization for hea
enalapril maleate tablet
ranbaxy pharmaceuticals inc. - enalapril maleate (unii: 9o25354epj) (enalaprilat anhydrous - unii:q508q118jm) - enalapril maleate 2.5 mg - hypertension enalapril maleate is indicated for the treatment of hypertension. enalapril maleate is effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of enalapril maleate and thiazides are approximately additive. heart failure enalapril maleate is indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. in these patients enalapril maleate improves symptoms, increases survival, and decreases the frequency of hospitalization (see clinical pharmacology, heart failure, mortality trialsfor details and limitations of survival trials). asymptomatic left ventricular dysfunction in clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction ≤35 percent), enalapril maleate decreases the rate of development of overt heart failure and decreases the incidence of hospitalization for heart failure (see clinical pharmacology, heart failur
teva-enalapril/hctz tablet
teva canada limited - enalapril sodium; hydrochlorothiazide - tablet - 4mg; 12.5mg - enalapril sodium 4mg; hydrochlorothiazide 12.5mg - angiotensin-converting enzyme inhibitors
teva-enalapril/hctz tablet
teva canada limited - enalapril sodium; hydrochlorothiazide - tablet - 8mg; 25mg - enalapril sodium 8mg; hydrochlorothiazide 25mg - angiotensin-converting enzyme inhibitors
vaseretic tablet
organon canada inc. - enalapril sodium (enalapril maleate); hydrochlorothiazide - tablet - 8mg; 25mg - enalapril sodium (enalapril maleate) 8mg; hydrochlorothiazide 25mg - angiotensin-converting enzyme inhibitors
enalapril actavis 5 mg tablet
actavis new zealand limited - enalapril maleate 5 mg - tablet - 5 mg
innozide 20 mg/12.5 mg tablets 20/12.5 milligram tablets
merck sharp and dohme limited - enalapril maleate hydrochlorothiazide - tablets - 20/12.5 milligram
enalapril hctz 20/12,5 austell tablets
austell pharmaceuticals (pty) ltd - tablets - not indicated - each tablet contains enalapril maleate 20,0 mg and hydrochlorothiazide 12,5 mg
enap-h tablets
krka d.d. - enalapril (enalapril maleate), hydrochlorothiazide - tablets - 10mg+ 25mg